{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:34:39Z","timestamp":1793237679012,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"F. Hoffmann-La Roche Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016606","name":"Riley Children's Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ymthe.2026.04.014","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T19:59:00Z","timestamp":1776283140000},"page":"3805-3819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Transient prophylactic immunosuppression with abatacept or dasatinib prevents immune responses in AAV gene transfer"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6549-8856","authenticated-orcid":false,"given":"Rebecca","family":"Xicluna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Gonzalez-Visiedos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calista M.","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Zaugg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Waiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Schwandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Otteneder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moanaro","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maite","family":"Mu\u00f1oz-Melero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep R.P.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland W.","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Haegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.04.014_bib1","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s40265-019-01162-5","article-title":"Onasemnogene Abeparvovec: First Global Approval","volume":"79","author":"Hoy","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.ymthe.2026.04.014_bib2","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s40265-022-01788-y","article-title":"Valoctocogene Roxaparvovec: First Approval","volume":"82","author":"Blair","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.ymthe.2026.04.014_bib3","series-title":"FDA Approves First Gene Therapy for Treatment of Certain Patients with Duchenne Muscular Dystrophy","year":"2023"},{"key":"10.1016\/j.ymthe.2026.04.014_bib4","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/oxfordjournals.aje.a120897","article-title":"Epidemiology of adenovirus-associated virus infection in a nursery population","volume":"88","author":"Blacklow","year":"1968","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ymthe.2026.04.014_bib5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jpeds.2020.11.054","article-title":"Thrombotic Microangiopathy Following Onasemnogene Abeparvovec for Spinal Muscular Atrophy: A Case Series","volume":"231","author":"Chand","year":"2021","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymthe.2026.04.014_bib6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ymthe.2020.12.007","article-title":"Current Clinical Applications of In Vivo Gene Therapy with AAVs","volume":"29","author":"Mendell","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.04.014_bib7","doi-asserted-by":"crossref","DOI":"10.1172\/JCI173510","article-title":"Thrombotic microangiopathy following systemic AAV administration is dependent on anti-capsid antibodies","volume":"134","author":"Salabarria","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.04.014_bib8","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1089\/hum.2022.138","article-title":"Immune responses and immunosuppressive strategies for adeno-associated virus-based gene therapy for treatment of central nervous system disorders: current knowledge and approaches","volume":"33","author":"Prasad","year":"2022","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2026.04.014_bib9","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3233\/JND-240002","article-title":"Meeting Report: 2023 Muscular Dystrophy Association Summit on \u2018Safety and Challenges in Gene Therapy of Neuromuscular Diseases","volume":"11","author":"Lek","year":"2024","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.ymthe.2026.04.014_bib10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/01926233241298892","article-title":"Systemic Toxicity of Recombinant Adeno-Associated Virus Gene Therapy Vectors","volume":"52","author":"Assaf","year":"2024","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ymthe.2026.04.014_bib11","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nm1549","article-title":"CD8+ T-cell responses to adeno-associated virus capsid in humans","volume":"13","author":"Mingozzi","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.04.014_bib12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s40265-023-01836-1","article-title":"Mitigating Serious Adverse Events in Gene Therapy with AAV Vectors: Vector Dose and Immunosuppression","volume":"83","author":"Ertl","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.ymthe.2026.04.014_bib13","series-title":"Sarepta Provides Safety Update for ELEVIDYS and Initiates Steps to Strengthen Safety in Non-Ambulatory Individuals with Duchenne","year":"2025"},{"key":"10.1016\/j.ymthe.2026.04.014_bib14","author":"Liu"},{"key":"10.1016\/j.ymthe.2026.04.014_bib15","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/j.ymthe.2025.03.037","article-title":"The curious case of AAV immunology","volume":"33","author":"Keeler","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.04.014_bib16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/mthe.2001.0441","article-title":"Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9","volume":"4","author":"Fields","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.04.014_bib17","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nm1358","article-title":"Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response","volume":"12","author":"Manno","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.04.014_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam6375","article-title":"Rescue of Pompe disease in mice by AAV-mediated liver delivery of secretable acid \u03b1-glucosidase","volume":"9","author":"Puzzo","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.04.014_bib19","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMc2212912","article-title":"Dystrophin Immunity after Gene Therapy for Duchenne\u2019s Muscular Dystrophy","volume":"388","author":"B\u00f6nnemann","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.04.014_bib20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41598-024-84077-w","article-title":"Immunologic investigations into transgene directed immune-mediated myositis following delandistrogene moxeparvovec gene therapy","volume":"15","author":"Potter","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2026.04.014_bib21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/hum.2023.056","article-title":"Immune Responses to Muscle-Directed Adeno-Associated Viral Gene Transfer in Clinical Studies","volume":"34","author":"Kumar","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2026.04.014_bib22","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1073\/pnas.1617726114","article-title":"Class I-restricted T-cell responses to a polymorphic peptide in a gene therapy clinical trial for \u03b1-1-antitrypsin deficiency","volume":"114","author":"Calcedo","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.04.014_bib23","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.3389\/fimmu.2020.01293","article-title":"B Cell Depletion Eliminates FVIII Memory B Cells and Enhances AAV8-coF8 Immune Tolerance Induction When Combined With Rapamycin","volume":"11","author":"Biswas","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2026.04.014_bib24","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1089\/humc.2017.146","article-title":"Safety of Intradiaphragmatic Delivery of Adeno-Associated Virus-Mediated Alpha-Glucosidase (rAAV1-CMV-hGAA) Gene Therapy in Children Affected by Pompe Disease","volume":"28","author":"Corti","year":"2017","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.04.014_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101216","article-title":"B cell focused transient immune suppression protocol for efficient AAV readministration to the liver","volume":"32","author":"Rana","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.04.014_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-3-642-54490-3_2","article-title":"Dasatinib","volume":"201","author":"Lindauer","year":"2014","journal-title":"Recent Results Cancer Res."},{"key":"10.1016\/j.ymthe.2026.04.014_bib28","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2083479","article-title":"Novel strategies for the mitigation of cytokine release syndrome induced by T cell engaging therapies with a focus on the use of kinase inhibitors","volume":"11","author":"Leclercq","year":"2022","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ymthe.2026.04.014_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002582","article-title":"Src\/lck inhibitor dasatinib reversibly switches off cytokine release and T cell cytotoxicity following stimulation with T cell bispecific antibodies","volume":"9","author":"Leclercq","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2026.04.014_bib30","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1172\/JCI122372","article-title":"Exposure to wild-type AAV drives distinct capsid immunity profiles in humans","volume":"128","author":"Kuranda","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.04.014_bib31","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/s41573-020-0081-9","article-title":"Targeting co-stimulatory molecules in autoimmune disease","volume":"19","author":"Edner","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2026.04.014_bib32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev.immunol.14.1.233","article-title":"CD28\/B7 system of T cell costimulation","volume":"14","author":"Lenschow","year":"1996","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2026.04.014_bib34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2165\/00063030-200620010-00004","article-title":"Abatacept","volume":"20","author":"Hervey","year":"2006","journal-title":"BioDrugs."},{"key":"10.1016\/j.ymthe.2026.04.014_bib35","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/sj.mt.6300377","article-title":"Transient Immunomodulation Allows Repeated Injections of AAV1 and Correction of Muscular Dystrophy in Multiple Muscles","volume":"16","author":"Lorain","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.04.014_bib36","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/jth.14757","article-title":"Blockade of the costimulatory CD28-B7 family signal axis enables repeated application of AAV8 gene vectors","volume":"18","author":"Frentsch","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ymthe.2026.04.014_bib37","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1056\/NEJMoa2119913","article-title":"Phase 1-2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B","volume":"387","author":"Chowdary","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.04.014_bib38","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1158\/1078-0432.CCR-07-4393","article-title":"Profound Inhibition of Antigen-Specific T-Cell Effector Functions by Dasatinib","volume":"14","author":"Weichsel","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2026.04.014_bib39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00280-007-0478-8","article-title":"Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL","volume":"61","author":"Kamath","year":"2008","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ymthe.2026.04.014_bib40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/13543784.2020.1727885","article-title":"CTLA4-Ig (abatacept): a promising investigational drug for use in type 1 diabetes","volume":"29","author":"Rachid","year":"2020","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ymthe.2026.04.014_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.672449","article-title":"Effect of CpG Depletion of Vector Genome on CD8+ T Cell Responses in AAV Gene Therapy","volume":"12","author":"Bertolini","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2026.04.014_bib42","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s40168-023-01578-y","article-title":"Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1","volume":"11","author":"Degraeve","year":"2023","journal-title":"Microbiome"},{"key":"10.1016\/j.ymthe.2026.04.014_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101551","article-title":"Innate immune response to AAV-based gene therapy vectors: Mechanisms of complement activation and cytokine release","volume":"33","author":"Xicluna","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.04.014_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.969633","article-title":"Costimulation blockade and Tregs in solid organ transplantation","volume":"13","author":"Muckenhuber","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2026.04.014_bib45","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ymthe.2017.02.014","article-title":"The Balance between CD8+ T Cell-Mediated Clearance of AAV-Encoded Antigen in the Liver and Tolerance Is Dependent on the Vector Dose","volume":"25","author":"Kumar","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.04.014_bib46","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1111\/ajt.13761","article-title":"Delayed Cytotoxic T Lymphocyte-Associated Protein 4-Immunoglobulin Treatment Reverses Ongoing Alloantibody Responses and Rescues Allografts From Acute Rejection","volume":"16","author":"Young","year":"2016","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.ymthe.2026.04.014_bib47","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fimmu.2015.00262","article-title":"Complement System Part I - Molecular Mechanisms of Activation and Regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2026.04.014_bib48","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s10875-011-9527-5","article-title":"CTLA-4-Ig therapy diminishes the frequency but enhances the function of Treg cells in patients with rheumatoid arthritis","volume":"31","author":"\u00c1lvarez-Quiroga","year":"2011","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.ymthe.2026.04.014_bib49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.smim.2009.02.005","article-title":"Memory T cells need CD28 costimulation to remember","volume":"21","author":"Boesteanu","year":"2009","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.ymthe.2026.04.014_bib50","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.4049\/jimmunol.1500940","article-title":"Cutting Edge: CTLA-4Ig Inhibits Memory B Cell Responses and Promotes Allograft Survival in Sensitized Recipients","volume":"195","author":"Chen","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2026.04.014_bib51","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3389\/fimmu.2019.00965","article-title":"Survival of Long-Lived Plasma Cells (LLPC): Piecing Together the Puzzle","volume":"10","author":"Lightman","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2026.04.014_bib52","doi-asserted-by":"crossref","first-page":"S325","DOI":"10.3233\/JND-210706","article-title":"The Effect of Immunomodulatory Treatments on Anti-Dystrophin Immune Response After AAV Gene Therapy in Dystrophin Deficient mdx Mice","volume":"8","author":"Li","year":"2021","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.ymthe.2026.04.014_bib53","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/08892229251370763","article-title":"The immunogenicity of AAV-encoded HIV-1 bNAbs in rhesus macaques is unaffected by a short course of the immunomodulator CTLA4Ig","volume":"41","author":"Hahn","year":"2025","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.ymthe.2026.04.014_bib54","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.omtm.2020.10.023","article-title":"Modulation of the liver immune microenvironment by the adeno-associated virus serotype 8 gene therapy vector","volume":"20","author":"Carestia","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.04.014_bib55","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/hum.2018.015","article-title":"Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN","volume":"29","author":"Hinderer","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2026.04.014_bib56","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.ymthe.2024.02.002","article-title":"High-dose systemic adeno-associated virus vector administration causes liver and sinusoidal endothelial cell injury","volume":"32","author":"Hordeaux","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.04.014_bib57","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.omtm.2019.08.015","article-title":"Clinical Considerations for Capsid Choice in the Development of Liver-Targeted AAV-Based Gene Transfer","volume":"15","author":"Pipe","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.04.014_bib58","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41434-021-00287-1","article-title":"Ultra-sensitive AAV capsid detection by immunocapture-based qPCR following factor VIII gene transfer","volume":"29","author":"Sandza","year":"2022","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2026.04.014_bib59","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/hum.2024.040","article-title":"Innate Immune Sensing of Adeno-Associated Virus Vectors","volume":"35","author":"Cao","year":"2024","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2026.04.014_bib60","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.3390\/v16101507","article-title":"Redundancy in Innate Immune Pathways That Promote CD8+ T-Cell Responses in AAV1 Muscle Gene Transfer","volume":"16","author":"Li","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2026.04.014_bib61","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1182\/blood-2016-11-751040","article-title":"Plasmacytoid and conventional dendritic cells cooperate in crosspriming AAV capsid-specific CD8+ T cells","volume":"129","author":"Rogers","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.04.014_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtm.2018.05.001","article-title":"Helper-free Production of Laboratory Grade AAV and Purification by Iodixanol Density Gradient Centrifugation","volume":"10","author":"Crosson","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.04.014_bib63","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1089\/hgtb.2015.037","article-title":"Determination of Anti-Adeno-Associated Virus Vector Neutralizing Antibody Titer with an In Vitro Reporter System","volume":"26","author":"Meliani","year":"2015","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.ymthe.2026.04.014_bib64","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/978-1-61779-370-7_11","article-title":"Measuring Immune Responses to recombinant AAV Gene Transfer","volume":"807","author":"Martino","year":"2011","journal-title":"Methods Mol. Biol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626002790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626002790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:27:09Z","timestamp":1793237229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626002790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":62,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1525001626002790"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.04.014","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transient prophylactic immunosuppression with abatacept or dasatinib prevents immune responses in AAV gene transfer","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}